None listed
Conditions
Brief summary
This study is a prospective, multi-centre, randomised clinical study comparing the preoperative radiographic plan to the intra-operative femoral stem sizing, and assessing post-operative fit, clinical and satisfaction outcomes. The study will be conducted in patients with Non-inflammatory Degenerative Joint Disease. In addition, a substudy is running in NZ to evaluate the differences in peri-prosthetic bone remodelling post hip replacement in 3 different femoral component implants. The Lunar iDXA (GE Healthcare, Madison, WI) densitometer is a Food and Drug Administration (FDA) - approved device for measuring BMD and body composition. The relationship between bone loss, patient functional outcome and implant survival across the 3 femoral stems will also be investigated.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
1.Patient are male or non-pregnant females requiring a cementless THR for non-inflammatory degenerative joint disease of the hip. 2.Must be older than 18 years
Exclusion criteria
1. Patient has a cognitive impairment, an intellectual disability or a mental illness 2. People whose primary language is other than English 3. Pregnant Women 4. Children and or/young people (ie. <18 years)